secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0001156039-25-000096
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance reaffirms FY2025 adjusted EPS guidance of $34.15-$34.85
----------------------------------------------------------------

- FY2025 GAAP EPS guidance $28.30-$29.00, including ~$5.85 net unfavorable items.
- Adjusted EPS guidance unchanged at $34.15-$34.85.
- Benefit expense ratio guidance reaffirmed at 89.1% ± 50 bps.
- Company expects 60% of adjusted EPS to be realized in first half of 2025.
- Officers reiterate guidance during investor meetings this week.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000096/0001156039-25-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000096/elv-20250528.htm
  HTML page:      https://secwatch.observer/filing/0001156039-25-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer